VanEck Pharmaceutical ETF
PPH
#1360
ETF rank
ยฃ0.77 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ US
Market
ยฃ84.49
Share price
-1.35%
Change (1 day)
30.80%
Change (1 year)

Expense ratio and fees for VanEck Pharmaceutical ETF (PPH)

Expense Ratio

Expense Ratio as of May 2025: 0.36%

Gross Expense Ratio

Gross Expense Ratio as of September 2026: 0.36%

Net Expense Ratio

Net Expense Ratio as of September 2026: 0.36%